A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia

被引：0
作者：
Valentina Gianfelici
Daniela Diverio
Massimo Breccia
Sonia Buffolino
Valentina Derme
Attilio Di Lascio
Marilisa Marinelli
Simona Santangelo
Giovanna Meloni
Robin Foà
机构：
[1] “Sapienza” University of Rome,Division of Hematology, Department of Cellular Biotechnologies and Hematology
来源：
Annals of Hematology | 2011年 / 90卷
关键词：
Acute Myeloid Leukemia; Acute Myeloid Leukemia Patient; Internal Tandem Duplication; Denature High Performance Liquid Chromatography; FLT3 Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：845 / 846
页数：1
相关论文
共 50 条
[41]   Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia [J].
Song, Moo-Kon ;
Park, Byeong-Bae ;
Uhm, Ji-Eun .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
[42]   FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia The Start of an Era? [J].
Pemmaraju, Naveen ;
Kantarjian, Hagop ;
Ravandi, Farhad ;
Cortes, Jorge .
CANCER, 2011, 117 (15) :3293-3304
[43]   De novo adult acute myeloid leukemia with two new mutations in juxtatransmembrane domain of the FLT3 gene: a case report [J].
Alarbeed, Ismael F. ;
Wafa, Abdulsamad ;
Moassass, Faten ;
Al-Halabi, Bassel ;
Al-Achkar, Walid ;
Liehr, Thomas ;
Aboukhamis, Imad .
JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
[44]   Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3 [J].
Martinez-Lopez, Joaquin ;
Castro, Nerea ;
Rueda, Daniel ;
Canal, Alicia ;
Grande, Carlos ;
Ayala, Rosa .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (04) :555-558
[45]   Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation [J].
Dan Xu ;
Yishan Chen ;
Ying Yang ;
Zhao Yin ;
Changfen Huang ;
Qiang Wang ;
Ling Jiang ;
Xuejie Jiang ;
Changxin Yin ;
Qifa Liu ;
Guopan Yu .
Journal of Translational Medicine, 20
[46]   Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation [J].
Xu, Dan ;
Chen, Yishan ;
Yang, Ying ;
Yin, Zhao ;
Huang, Changfen ;
Wang, Qiang ;
Jiang, Ling ;
Jiang, Xuejie ;
Yin, Changxin ;
Liu, Qifa ;
Yu, Guopan .
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[47]   FLT3 Mutation Testing in AcuteMyeloid Leukemia [J].
Gupta, Arjun ;
Viswanatha, David S. ;
Patnaik, Mrinal M. .
JAMA ONCOLOGY, 2017, 3 (07) :991-992
[48]   Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia [J].
Mattison, Ryan J. ;
Ostler, Kelly R. ;
Locke, Frederick L. ;
Godley, Lucy A. .
REVIEWS ON RECENT CLINICAL TRIALS, 2007, 2 (02) :135-141
[49]   FLT3 inhibition as a targeted therapy for acute myeloid leukemia [J].
Sanz, Miguel ;
Burnett, Alan ;
Lo-Coco, Francesco ;
Lowenberg, Bob .
CURRENT OPINION IN ONCOLOGY, 2009, 21 (06) :594-600
[50]   Clinical use of FLT3 inhibitors in acute myeloid leukemia [J].
Sutamtewagul, Grerk ;
Vigil, Carlos E. .
ONCOTARGETS AND THERAPY, 2018, 11 :7041-7052
12345